Abiopharma

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088497 Size: 5 KB

New Form D - Indaptus Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015841 Size: 18 KB

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’sAtaxia

New Form 4 - Akari Therapeutics Plc Filed: 2025-06-20 AccNo: 0000950170-25-088490 Size: 4 KB

New Form 4 - AGENUS INC Filed: 2025-06-20 AccNo: 0000950170-25-088491 Size: 5 KB

New Form 8-K - Axogen, Inc. Filed: 2025-06-20 AccNo: 0000805928-25-000095 Size: 171 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 4 - AGENUS INC Filed: 2025-06-20 AccNo: 0000950170-25-088492 Size: 5 KB

New Form SCHEDULE 13D/A - GLYCOMIMETICS INC Filed: 2025-06-20 AccNo: 0000902664-25-002765 Size: 10 KB

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088489 Size: 6 KB

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

New Form 4 - Cencora, Inc. Filed: 2025-06-20 AccNo: 0001140859-25-000107 Size: 8 KB

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088487 Size: 5 KB

New Form 8-K - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-20 AccNo: 0001628280-25-032358 Size: 163 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088486 Size: 5 KB

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088484 Size: 5 KB